Lv2
102 积分 2025-11-21 加入
Emergence of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli ST167 Prior to Clinical Use: A Multifactored Resistance Landscape
14小时前
求助中
Comment on “Cefiderocol Susceptibility Rates in Carbapenem-Resistant Gram-Negative Bacteria in a Comparative, Multicenter Surveillance Study in China”
29天前
已完结
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
1个月前
已完结
Multivalent Display of Antimicrobial Peptides on Plant Virus Scaffolds Enhances Killing of Drug-Resistant Bacteria
1个月前
已完结
In vitro activity of cefiderocol and sulbactam-durlobactam against clinical-isolated carbapenem-resistant Acinetobacter baumannii from China
2个月前
已完结
In-vitro evaluation of Cefiderocol and Ceftazidime/Avibactam against MDR and XDR gram-negative pathogens from clinical isolates, with whole genome sequencing-based analysis of Antimicrobial Resistance Genes in Cefiderocol-resistant Escherichia coli
2个月前
已完结
Infectious Diseases: What You May Have Missed in 2025
2个月前
已完结
Cefiderocol for the treatment of difficult-to-treat resistance in Pseudomonas aeruginosa ventriculitis
4个月前
已完结
Current Management Strategies for Stenotrophomonas maltophilia
4个月前
已关闭
Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China
4个月前
已完结
皖公网安备34019202002308
